<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04826757</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01039-30</org_study_id>
    <nct_id>NCT04826757</nct_id>
  </id_info>
  <brief_title>Effectiveness of Coordinated Care to Reduce the Prolonged Disability Risk Among Patients Suffering From Low Back Pain in Primary Care</brief_title>
  <acronym>COLOMB</acronym>
  <official_title>Effectiveness of Coordinated Care to Reduce the Risk of Prolonged Disability Among Patients Suffer From Subacute or Recurrent Acute Low Back Pain in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Common low back pain affects about 23% of general population and can be associated with&#xD;
      psychosocial difficulties and prolonged inability to work. Its management in France mainly&#xD;
      depends on general practioners, and sometime on physiotherapists.&#xD;
&#xD;
      A coordinated care between general practioners, physiotherapists and occupational health&#xD;
      services would help to improve the care pathway for patients and health professionals.&#xD;
&#xD;
      The main objective is to assess the impact of coordinated primary care and deployed at the&#xD;
      territories' level, in subacute or acute recurrent low back pain patients in comparison with&#xD;
      the standard care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">April 2026</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised, controlled, cluster trial. the project is multicentered.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived inability at 1 year</measure>
    <time_frame>Enrollment to 12 months follow up</time_frame>
    <description>Ratio of patient presenting improvement equal or above 4 points of Roland Morris Disability Questionnaire. The minimum value of Roland Morris Disability Questionnaire is 0 and the maximun value is 24. A higher score mean worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perceived inability</measure>
    <time_frame>Enrollment to 3 months follow up, Enrollment to 6 months follow up</time_frame>
    <description>Ratio of patient presenting improvement equal or above 4 points of Roland Morris Disability Questionnaire. The minimum value of Roland Morris Disability Questionnaire is 0 and the maximun value is 24. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roland Morris Disability score over time</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of Roland Morris Disability Questionnaire over time. The minimum value is 0 and the maximun value is 24. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain perceived</measure>
    <time_frame>Enrollment - 3 months , Enrollment - 6 months and Enrollment -12 months</time_frame>
    <description>Ratio of patients presenting improvement equal or above 2 points of numerical pain scale The minimum value is 0 and the maximun value is 10. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical pain scale over time</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of numerical pain scale over time. The minimum value is 0 and the maximun value is 10. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occupational status</measure>
    <time_frame>at 3 months, 6 months and 12 months</time_frame>
    <description>Ratio of patients having an active occupation (defined by have an employment and be present at work )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Employment rate</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of employment rate over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sick leave</measure>
    <time_frame>during 12 months after inclusion</time_frame>
    <description>number of sick leave days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved patients</measure>
    <time_frame>at 3 months, 6 months and 12 months</time_frame>
    <description>Ratio of improved patients. Improved patients is defined by patient presenting improvement equal or above 4 points of Roland Morris Disability Questionnaire and improvement equal or above 2 points of numerical pain scale and having a active occupational</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of improved patients ratio</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of improved patients ratio over time Improved patients is defined by patient presenting improvement equal or above 4 points of Roland Morris Disability Questionnaire and improvement equal or above 2 points of numerical pain scale and having a active occupational</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental component score of Short Form -12</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of mental scores over time The mental component score is determined by 4 categories of Short Form -12. The minimum value of each category is 0 and the maximun value is 100. A higher score mean better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical component score of Short Form -12</measure>
    <time_frame>Enrollment, 3 months, 6 months, 12 months</time_frame>
    <description>Evolution of physical scores over time. The physical component score is determined by 4 categories of Short Form -12. The minimum value of each category is 0 and the maximun value is 100. A higher score mean better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occupational component score of Fear Avoidance Beliefs Questionnaire</measure>
    <time_frame>Enrollment, 3 months, 12 months</time_frame>
    <description>Evolution of occupational component score over time. Occupational component is assessed using the Fear Avoidance Beliefs Questionnaire.&#xD;
The minimum value is 0 and the maximun value is 42. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity component score of Fear Avoidance Beliefs Questionnaire</measure>
    <time_frame>Enrollment, 3 months, 12 months</time_frame>
    <description>Evolution of physical activity component score over time. Physical activity component is assessed using the Fear Avoidance Beliefs Questionnaire.&#xD;
The minimum value is 0 and the maximun value is 24. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety component score of Hospital Anxiety and Depression Scale</measure>
    <time_frame>Enrollment 3 months, 12 months</time_frame>
    <description>Evolution of Anxiety score over time Anxiety Component is assessed using the Hospital Anxiety and Depression Scale The minimum value is 0 and the maximun value is 21. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression component score of Hospital Anxiety and Depression Scale</measure>
    <time_frame>Enrollment, 3 months, 12 months</time_frame>
    <description>Evolution of Depression score over time Depression component is assessed using the Hospital Anxiety and Depression Scale The minimum value is 0 and the maximun value is 21. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coordination care score of Patient Centered Coordination by a Care Team questionnaire</measure>
    <time_frame>Enrollment, 3 months, 12 months</time_frame>
    <description>Evolution of coordination care score over time This score is assessed by using Patient Centered Coordination by a Care Team questionnaire.&#xD;
The minimum value is 0 and the maximun value is 42. A higher score mean better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GP satisfaction related to patient care</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of GP satisfaction using an numerical scale The minimum value is 0 and the maximun value is 10. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiotherapist satisfaction related to patient care</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of physiotherapist satisfaction using an numerical scale The minimum value is 0 and the maximun value is 10. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Professionals trained for intervention</measure>
    <time_frame>Baseline intervention formations</time_frame>
    <description>number of professionals trained for intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomechanical component score of Pain Attitudes and Beliefs score - for intervention physiotherapists</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of Biomechanical component score for intervention physiotherapists. Biomechanical component is assessed using the Pain Attitudes and Beliefs Score. The minimum value is 10 and the maximun value is 60. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biopsychosocial component score of Pain Attitudes and Beliefs score - for intervention physiotherapists</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of Biopsychosocial component score for intervention physiotherapists. Biopsychosocial component is assessed using the Pain Attitudes and Beliefs Score.The minimum value is 9 and the maximun value is 54. A higher score mean better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biopsychosocial component score of Pain Attitudes and Beliefs score - for GPs</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of Biopsychosocial component score for GPs. Biopsychosocial component is assessed using the Pain Attitudes and Beliefs Score.The minimum value is 9 and the maximun value is 54. A higher score mean better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomechanical component score of Pain Attitudes and Beliefs score - for GPs</measure>
    <time_frame>T0 = baseline (cluster initiation); T1 = 1 year (6 months after inclusion of the 5th cluster patient); T2 = through study completion, an average of 3 years (12 months after the last cluster patient inclusion)</time_frame>
    <description>Evolution of Biomechanical component score for GPs. Biomechanical component is assessed using the Pain Attitudes and Beliefs Score. The minimum value is 10 and the maximun value is 60. A higher score mean worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Professional dialogues</measure>
    <time_frame>during the 12 months of follow up</time_frame>
    <description>Number and types of dialogues between GP and other professionals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of consultations or sessions</measure>
    <time_frame>during the 12 months of follow up</time_frame>
    <description>Number of consultations or sessions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard care for low back pain management by general practioners (GPs). the physiotherapist and occupational health services can be solicited independently by the patient or GP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>coordinated care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coordinated care between general practioners, physiotherapist and occupational health services.&#xD;
An intervention training will be performed before the start of the study for any care professional's to elaborate coordination tools and have an active communication.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinated care</intervention_name>
    <description>Coordinated care between general practioners; physiotherapists and occupational health services.&#xD;
Early contact with occupational health service by the general practioner and use of occupational retention tool Active physiotherapy (Individual active, intensive and regular rehabilitation program with 15 sessions of 1 hour, at a rate of 2 or 3 sessions per week)</description>
    <arm_group_label>coordinated care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient consulting an investigator GP for subacute low back pain or acute recurrent&#xD;
             low back pain&#xD;
&#xD;
          -  Patient with occupational activity (including sick leave)&#xD;
&#xD;
          -  Patient depending of occupational health service&#xD;
&#xD;
          -  Obtaining the signature of the consent to participate in this trial&#xD;
&#xD;
          -  Patient Registered with social security scheme&#xD;
&#xD;
        Non-inclusion Criteria:&#xD;
&#xD;
          -  Specific low back pain (fracture, infection, osteoporosis, inflammatory disease,&#xD;
             tumor)&#xD;
&#xD;
          -  Low back pain with sciatic, cruralgia&#xD;
&#xD;
          -  Contraindication to active reeducation&#xD;
&#xD;
          -  Impossibility to follow up during 12 months&#xD;
&#xD;
          -  Disability to write or read french&#xD;
&#xD;
          -  Adult patient protected under the law (guardianship),&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient women&#xD;
&#xD;
          -  Persons deprived of their liberty by judicial or administrative decision&#xD;
&#xD;
          -  Persons subject to legal protection measures&#xD;
&#xD;
          -  Persons unable to consent&#xD;
&#xD;
          -  Persons on coercion psychiatric care&#xD;
&#xD;
          -  Physiotherapy by a physiotherapist who don't participate in this trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aline RAMOND ROQUIN, MD-PHD</last_name>
    <phone>0241735867</phone>
    <phone_ext>+33</phone_ext>
    <email>aline.ramond@univ-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anthea LOIEZ</last_name>
    <phone>0241735867</phone>
    <phone_ext>+33</phone_ext>
    <email>anthea.loiez@univ-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cluster Bonchamp</name>
      <address>
        <city>Bonchamp-lès-Laval</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Ghislaine JUDALET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cédric HAMON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annelore DEFOIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margaux RIPAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra ROBINO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe BUCHARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian DUROY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Vaunoise</name>
      <address>
        <city>Breteil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Cholet</name>
      <address>
        <city>Cholet</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Château Gontier</name>
      <address>
        <city>Château-Gontier</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Héloïse ROGER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cluster Châteauneuf sur Sarthe / Morannes</name>
      <address>
        <city>Châteauneuf-sur-Sarthe</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Clisson</name>
      <address>
        <city>Clisson</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Conlie</name>
      <address>
        <city>Conlie</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Guillaume FETIVEAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jessica GUELFF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noémie QUEANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christèle TOURNELLE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arthur VIGNAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Craon Renaze Cosse</name>
      <address>
        <city>Craon</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Aline RAMOND ROQUIN, MD-PHD</last_name>
    </contact>
    <investigator>
      <last_name>Anne PLESSIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlene LESAGE BESNIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Michel MONNIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lydie GENDRY ROSSIGNOL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maryline MERIENNE COUSSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca NAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Didier MORIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Roche sur Yon</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Chantenay</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Dinan / Quévert / Plouasne</name>
      <address>
        <city>Quévert</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Rennes Nord Ouest</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Hoël CHARBONNEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Caroline JEHANNO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna JARNO-JOSSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adeline JOUANNIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muriel CABOTTE CARILLON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agathe LANFRANCONI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romain NIFENECKER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Rocquefort</name>
      <address>
        <city>Roquefort les pins</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster Savenay</name>
      <address>
        <city>Savenay</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cluster SEGRE</name>
      <address>
        <city>Segré</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Stéphane FREZE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Héloise GISLARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile BOURGEOIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles GUSTIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jérôme NUEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Angers- Trélazé</name>
      <address>
        <city>Trélazé</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Clément GUINEBERTEAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sandra NETO-ANNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric DE GROSSOUVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluster Vence</name>
      <address>
        <city>Vence</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

